Eribulin Mesylate, CAS [[441045-17-6]]

Produktübersicht

• Artikelname: Eribulin Mesylate, CAS [[441045-17-6]]
• Artikelnummer: BYT-ORB1089624
• Hersteller Artikelnummer: orb1089624
• Alternativnummer: BYT-ORB1089624-5
• Hersteller: Biorbyt
• Kategorie: Biochemikalien

Produktbeschreibung

Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma.

Produkteigenschaften

• Molekulargewicht: 826.00222
• CAS Nummer: [441045-17-6]
• Formel: C40H59NO11.CH4O3S